TANGO THERAPEUTICS INC. - COMMON STOCK

Tango Therapeutics Announces FDA Clearance of Investigational New Drug Application for TNG260, a First-in-Class CoREST Inhibitor for the Treatment of STK11-Mutant Cancers

03 أبريل 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Tango Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Highlights

27 مارس 2023 06:00:01 بحسب Nasdaq GlobeNewswire

Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Programs at the American Association of Cancer Research 2023 Annual Meeting

14 مارس 2023 19:11:45 بحسب Nasdaq GlobeNewswire

Tango Therapeutics Announces Limited Exposure to Silicon Valley Bank

10 مارس 2023 21:15:27 بحسب Nasdaq GlobeNewswire

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 مارس 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Tango Therapeutics to Participate in Upcoming Investor Conferences

01 مارس 2023 06:00:01 بحسب Nasdaq GlobeNewswire

Tango Therapeutics to Participate in Upcoming Investor Conferences

02 فبراير 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Tango Therapeutics Announces FDA Clearance of Investigational New Drug Application for TNG462; Provides Additional Business Updates

25 يناير 2023 06:00:00 بحسب Nasdaq GlobeNewswire

Tango Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Highlights

10 نوفمبر 2022 06:00:03 بحسب Nasdaq GlobeNewswire

Tango Therapeutics to Participate in Upcoming Investor Conferences

07 نوفمبر 2022 06:00:01 بحسب Nasdaq GlobeNewswire

Tango Therapeutics Announces Presentation of Preclinical Data on PRMT5 Inhibitors TNG908 and TNG462 in Three Abstracts Accepted at 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

19 أكتوبر 2022 06:00:01 بحسب Nasdaq GlobeNewswire

Tango Therapeutics Announces Presentation of Preclinical Data on TNG260 and Discovery Platform Advances at SITC 37th Annual Meeting

05 أكتوبر 2022 07:10:00 بحسب Nasdaq GlobeNewswire

Tango Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

06 سبتمبر 2022 06:00:01 بحسب Nasdaq GlobeNewswire

Tango Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Highlights

10 أغسطس 2022 06:00:00 بحسب Nasdaq GlobeNewswire

Tango Therapeutics to Participate in the 13th Annual Wedbush PacGrow Healthcare Conference

02 أغسطس 2022 06:00:01 بحسب Nasdaq GlobeNewswire

Tango Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes

27 يونيو 2022 06:00:00 بحسب Nasdaq GlobeNewswire

Tango Therapeutics to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference

08 يونيو 2022 06:00:01 بحسب Nasdaq GlobeNewswire

Tango Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights

11 مايو 2022 06:00:01 بحسب Nasdaq GlobeNewswire

Tango Therapeutics to Participate in the Guggenheim Synthetic Lethality Day 2022

09 مايو 2022 06:00:02 بحسب Nasdaq GlobeNewswire

Tango Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights

28 مارس 2022 06:00:01 بحسب Nasdaq GlobeNewswire